TP53 and cancer: As expected, in 23 of 29 cancer types analyzed, TP53 expression is significantly lower in TP53-truncated cancers than in other TP53-mutated cancers, and in the other six cancer types TP53 expression does not significantly differ between them (P-value < 0.05, Supplementary Table S15).